Differentiating multipotent mesenchymal stromal cells generate factors that exert paracrine activities on exogenous MSCs: Implications for paracrine activities in bone regeneration

Transplantability and therapeutic effects of bone marrow-derived mesenchymal cells in children with osteogenesis imperfecta

Edwin M. Horwitz, Darwin J. Prockop, Lorraine A. Fitzpatrick et al. · Nature Medicine · 1999 · 1.8K citations

Tissue Engineering, Regenerative Medicine, Cell Therapy +12

Isolated allogeneic bone marrow-derived mesenchymal cells engraft and stimulate growth in children with osteogenesis imperfecta: Implications for cell therapy of bone

Edwin M. Horwitz, Patricia Gordon, Winston K. K. Koo et al. · Proceedings of the National Academy of Sciences · 2002 · 1.6K citations · Full text

Tissue Engineering, Cell Therapy, Adult Stem Cell +21

Mutations in <i>SERPINF1</i> cause osteogenesis imperfecta type VI

Erica P. Homan, Frank Rauch, Ingo Grafe et al. · Journal of Bone and Mineral Research · 2011 · 185 citations · Full text

Bone Fragility, Developmental Biology, Oi Type Vi +14

Immunogenicity of enhanced green fluorescent protein (EGFP) in BALB/c mice: identification of an H2-Kd-restricted CTL epitope

Andrea Gambotto, Grzegorz Dworacki, Vito R. Cicinnati et al. · Gene Therapy · 2000 · 181 citations

Knockout Mouse, Signal Transduction, Immunology +7

Intrauterine transplantation of human fetal mesenchymal stem cells from first-trimester blood repairs bone and reduces fractures in osteogenesis imperfecta mice

Pascale V. Guillot, Oyebode Abass, J. H. Duncan Bassett et al. · Blood · 2007 · 181 citations · Full text